by Eric Christianson | Jul 21, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Paroxetine is from the family of SSRIs (selective serotonin reuptake inhibitors. It has been around for a long time and is indicated for depression, anxiety, and many other psychiatric indications just like other SSRIs. It doesn’t get much love from healthcare...
by Eric Christianson | May 1, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls, Women’s and Men’s Health Medication and Disease State Clinical Pearls
Depression is one of the top three health disorders in adults ages 18-34 with approximately 21.3% of these adults having depression. This means that many women suffer from depression during their peak childbearing years and will begin medication to treat it....
by Eric Christianson | Mar 19, 2023 | Endocrine Medication and Disease State Clinical Pearls
Tirzepatide is a newer medication that is likely to get significant use in Type 2 diabetes and weight management. With the help of a wonderful pharmacy student, we previously did a tirzepatide clinical breakdown which you can find here. Tirzepatide avoids many drug...
by Eric Christianson | Aug 30, 2020 | Medication and Disease State Clinical Pearls For Pharmacists, Women’s and Men’s Health Medication and Disease State Clinical Pearls
If you are a healthcare professional, inevitably, questions about the use of antidepressants in pregnancy come up in clinical practice. Why is paroxetine generally avoided in pregnancy? The primary reason that paroxetine is avoided in pregnancy is that it has...
